Company profile
Biopharmaceuticals · Princeton, New Jersey, USA · bms.com
Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing, delivering innovative medicines for serious diseases. The company leverages its BioPharma strategy to combine the reach of a major pharmaceutical firm with the agility of a biotech company.
Focus on cancer treatments to address unmet medical needs.
Leadership in oncology with a heritage in treating solid tumors.
Our company: Industry leadership in BioPharma - Bristol Myers Squibb
Develop therapies for blood-related disorders.
Known for delivering many transformational firsts in hematology.
Our company: Industry leadership in BioPharma - Bristol Myers Squibb
Address autoimmune diseases through innovative treatments.
Committed to breaking new ground across diseases with high unmet need.
Our company: Industry leadership in BioPharma - Bristol Myers Squibb
Enhance heart disease treatments with advanced research.
Leveraging experience to take cardiovascular research to the next level.
Our company: Industry leadership in BioPharma - Bristol Myers Squibb
Bristol Myers Squibb is advancing its technological capabilities to enhance research, development, patient care.
The company is actively integrating AI and data-driven decision-making across its R&D continuum.
This is a neutral public preview. Sign in to generate your own personalized brief, with stakeholder angles, talk tracks and where your solution fits, tailored to how you sell.
Generate a full briefYour first brief is free, no card required.
Evidence confidence 90/100. Generated 2026-07-08 from public sources.